Elsevier's Biochimica et Biophysica Acta (BBA) Journal Series Adds Open Access Journal: BBA Clinical to its Portfolio

Elsevier's Biochimica et Biophysica ActaElsevier's Biochimica et Biophysica Acta (BBA) Journal Series Adds Open Access Journal: BBA Clinical to its Portfolio PR Newswire OXFORD, England, November 13, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of BBA Clinical, the first full open access journal within the Biochimica et Biophysica Acta (BBA) journal series. BBA Clinical will focus on translating molecular insights into clinical research. BBA Clinical is a biomedical journal dedicated to publishing research on the molecular basis of human diseases, as well as presenting findings from clinical trials that target biochemical pathways and processes. All articles in BBA Clinical describe, in part or entirely, studies using human patient samples or human cohorts. Clinical areas of particular interest include aging, cancer, cardiovascular-, metabolic-, neurological-, and immunological diseases; the interactions that may occur among these different diseases and conditions; and studies that examine their early or pre-symptomatic states. Cross-sectional and prospective studies from well-established cohorts, and studies involving imaging methodologies, are particularly encouraged for submission.